查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
腸道管理系統市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)
市場調查報告書
商品編碼
1190134

腸道管理系統市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Bowel Management Systems Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，腸道管理系統市場的複合年增長率預計為 3.3%。

在 COVID-19 大流行期間，因 COVID-19 感染而增加的其他健康並發症也在增加。 2022 年 1 月的冠狀病毒監測流行病學研究排除 (SECURE-IBD) 數據庫報告發現，COVID-19 不良事件與 IBD 患者的年齡和其他合併症有關。 新型嚴重急性呼吸系統綜合症相關冠狀病毒在進入胃腸道後會啟動先天性和適應性免疫反應的激活。 炎症反應的表達被認為會導致 IBD 患者的腸道疾病。 根據 2020 年 10 月世界胃腸病學雜誌的一篇評論，發現許多 COVID-19 患者出現胃腸道不適。 因此，對腸道管理系統的需求不斷增長，以管理因 COVID-19 感染可能引起的進一步並發症。 然而，在大流行後時期，全球範圍內解除限制限制預計將推動對腸道管理系統的需求。

推動市場增長的關鍵因素是炎症性腸病發病率上升和技術不斷進步。 事實證明，全球越來越多的老年人口容易出現便秘、腹瀉和其他腸道疾病，這有助於推動腸道管理系統市場的發展。 例如，根據CDC在2021年4月（5月19日）世界IBD日發布的報告，2020年全球將有大約700萬IBD患者。

IBD 患者患癌症、關節炎、偏頭痛和其他心血管、呼吸系統、腎臟和肝臟疾病等慢性疾病的患病率高於非 IBD 患者。 根據上述資料，我們發現在老年人（64 歲及以上）中，IBD 患者更有可能因髖部骨折住院。 我們還發現 30 天再入院和住院時間更長。 因此，預計老年人口的再入院風險將推動對腸道管理系統的需求，並有助於預測期內的市場增長。

此外，腸道管理系統對脊髓損傷、多發性硬化症、帕金森氏病、阿爾茨海默氏病、腦腫瘤、慢性便秘、臥床不起的患者以及無法正常排便的兒童等神經系統疾病患者的有效性. 業績有望提振市場增長。

因此，上述因素預計將在預測期內推動市場增長。

腸道管理系統市場趨勢

結腸造口袋細分市場有望佔據腸道管理系統市場最大份額

腸易激綜合症、多發性硬化症、克羅恩病和癌症等腸道疾病的高發病率和相關健康並發症已導致結腸造口袋部分在市場上佔據主導地位。預計將佔據很大的市場份額。 因此，結腸造口袋市場預計將受到慢性病患病率上升的推動。

克羅恩病是炎症性腸病 (IBD) 的一種形式，可影響從口腔到肛門的胃腸道的任何部分，推動結腸造口袋段。 根據克羅恩病和結腸炎組織在 2022 年發表的一篇文章，英國每年每 123 人中就有 1 人患有克羅恩病。

此外，增加產品開發和臨床試驗預計將有助於增加對結腸造口袋的需求，從而促進研究部門的增長。 例如，2021 年 12 月，Coloplast 啟動了一項臨床試驗，以測試 Heylo 的有效性，Heylo 是一種使用傳感器警告患者結腸造口袋洩漏並建議他們如何防止洩漏的產品。。

因此，上述因素預計將在預測期內推動所研究細分市場的增長。

北美主導市場，預計在預測期內也會如此

在預測期內，預計北美將主導腸道管理系統市場。 這是由於結直腸癌患病率上升和人口老齡化等因素造成的。 然而，根據美國癌症協會的數據，到 2022 年 1 月，大約每 23 名男性中就有 1 名終生有患結直腸癌的風險，每 25 名女性中就有 1 名將成為風險因素。 此外，患者認知度的提高、腸道管理系統採用率的提高、產品開發投入的增加、優秀醫療基礎設施的建立、開發產品的接受度高也是確保該地區優勢地位的主要因素之一。 .

例如，2021年7月，造口專業製造商Trio Healthcare從美國金融公司SWK Holdings Inc.獲得了約1000萬美元的第二輪融資，用於生產Trio的造口袋“Genii”。我們已經籌集了資金.

因此，上述因素預計將在預測期內推動該地區的增長。

腸道管理系統市場競爭分析

腸道管理系統市場本質上是高度分散的，因為存在多家在全球和區域運營的公司。 從市場份額的角度來看，目前幾家大型企業佔據了市場主導地位。 目前主導市場的公司包括 Medtronic PLC、Becton Dickinson and Company、B. Braun Melsungen AG、Coloplast Pty Ltd 和 ConvaTec Inc。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 炎症性腸病的高發率
    • 老年人口增加
  • 市場製約因素
    • 患者越來越喜歡非侵入性治療
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按產品分類
    • 結腸造口袋
    • 灌溉系統
    • 神經調節裝置
    • 其他產品
  • 按患者類型
    • 成人
    • 兒科
  • 最終用戶
    • 醫院
    • 門診
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Medtronic PLC
    • Becton, Dickinson and Company
    • B. Braun Melsungen AG
    • Coloplast Pty Ltd
    • ConvaTec Group PLC
    • Consure Medical Pvt. Ltd
    • Cogentix Medical
    • Hollister Incorporated
    • ABC Medical Supply Inc.
    • Laborie Inc.

第7章 市場機會今後動向

簡介目錄
Product Code: 67868

The bowel management systems market is anticipated to register a CAGR of 3.3% during the forecast period.

Amidst the outbreak of the COVID-19 pandemic, there has been a rise in other health complications that rose with COVID-19 infections. According to a report by the Surveillance Epidemiology of Coronavirus Under Research Exclusion (SECURE-IBD) database in January 2022, adverse COVID-19 outcomes were associated with age and other co-morbidities among patients with IBD. The novel severe acute respiratory syndrome-related coronavirus initiates activation of innate and adaptive immune responses upon entering the gastrointestinal tract. The onset of inflammatory reactions can supposedly induce intestinal damage in IBD patients. As per a review article in the World Journal of Gastroenterology in October 2020, it was comprehended that many COVID-19 patients were found to develop gastrointestinal complaints. Thus, there is an increasing demand for bowel management systems to manage further complications that could develop due to COVID-19 infection. However, the relaxation of the lockdown restrictions during the post-pandemic period is expected to drive the demand for the bowel management system due to the lifting of lockdowns across the world.

The significant factor attributing to the market's growth is the rising incidence of inflammatory bowel diseases and increasing technological advancement. The increasing geriatric population across the world is found to be more prone to constipation, diarrhea, and other bowel conditions that help to drive the bowel management systems market. For instance, according to a report by the CDC, published in April 2021 on World IBD Day (May 19), the number of people affected by IBD around the world was approximately 7 million in 2020.

The prevalence of chronic health conditions, such as cancer, arthritis, migraine, and other cardiovascular, respiratory, kidney, and liver diseases, are higher in IBD patients than in non-IBD patients. As per the source mentioned above, in the older population (above 64 years), patients with IBD were more susceptible to hospitalization for hip fractures. Also, they were found to have 30-day readmissions and longer hospital stays. Hence, the readmission risks among the elderly population are expected to drive the demand for bowel management systems, thereby contributing to the market's growth over the forecast period.

It also indicated the efficacy of bowel management systems in people with neurological disorders, such as spinal cord injury, multiple sclerosis, Parkinson's disease, Alzheimer's disease, brain tumors, chronic constipation, bedridden patients, and children unable to pass stool regularly, and properly, are expected to boost the growth of the market.

Thus, the above-mentioned factors are expected to drive the market's growth during the forecast period.

Bowel Management Systems Market Trends

Colostomy Bags Segment is Expected to Hold the Largest Market Share in the Bowel Management Systems Market

The colostomy bags segment is expected to hold the dominant share in the market, owing to the factors such as high incidence rates and health complications associated with bowel diseases, such as irritable bowel syndrome, multiple sclerosis, Crohn's disease, and cancer. The market for colostomy bags is therefore expected to be driven by the rising incidence of chronic diseases.

Crohn's disease is a form of inflammatory bowel disease (IBD) that can impact any portion from the mouth to the anus of the gastrointestinal tract, which boosts the colostomy bag segment. As per the article published in 2022 by Crohn's and Colitis Organization, one in every 123 people in United Kingdom has had Crohn's disease annually.

Also, the increasing product developments and clinical trials are expected to contribute to the growing demand for colostomy bags, thereby boosting the growth of the studied segment. For instance, in December 2021, Coloplast launched a clinical trial to test the effect of its ostomy product, Heylo, a product that uses sensors to warn patients with colostomy bags about leakage and advise them about how to prevent it.

Thus, the above-mentioned factors are expected to drive the growth of the studied segment during the forecast period.

North America is Expected to Dominate the Market and is Expected to do Same in the Forecast Period

North America is expected to dominate the bowel management systems market over the forecast period. This is owing to factors such as the rising prevalence of colorectal cancer and the growing geriatric population. However, according to the American Cancer Society, in January 2022, about one in 23 males was at a lifetime risk of developing colorectal cancer, and the risk factor among women was one in 25. Additionally, increased patient awareness, rising adoption rates of intestinal management systems, increasing investments in product development, excellently-established healthcare infrastructure, and strong acceptance of developed products are also some of the key factors ensuring the dominance of the region.

For instance, in July 2021, the Ostomy Specialist Trio Healthcare secured a second round of funding from US finance company SWK Holdings corporation of approximately USD 10 million in total for manufacturing Trio's stoma bags, Genii.

Thus, the above-mentioned factors are expected to drive the growth of the region during the forecast period.

Bowel Management Systems Market Competitive Analysis

The bowel management systems market is considerably fragmented in nature due to the presence of several companies operating globally as well as regionally. In terms of market share, a few of the major players are currently dominating the market. Some of the companies, which are currently dominating the market, are Medtronic PLC, Becton Dickinson and Company, B. Braun Melsungen AG, Coloplast Pty Ltd, and ConvaTec Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Incidence of Inflammatory Bowel Disease
    • 4.2.2 Rising Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Patient's Greater Preference for Non-invasive Treatment
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Colostomy Bags
    • 5.1.2 Irrigation Systems
    • 5.1.3 Nerve Modulation Devices
    • 5.1.4 Other Products
  • 5.2 By Patient Type
    • 5.2.1 Adults
    • 5.2.2 Paediatric
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic PLC
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 B. Braun Melsungen AG
    • 6.1.4 Coloplast Pty Ltd
    • 6.1.5 ConvaTec Group PLC
    • 6.1.6 Consure Medical Pvt. Ltd
    • 6.1.7 Cogentix Medical
    • 6.1.8 Hollister Incorporated
    • 6.1.9 ABC Medical Supply Inc.
    • 6.1.10 Laborie Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS